Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL30027320

CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.[Ru+2]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 4/20 0.92
▸ SLC22A2 O15244 1/20 0.79
▸ TSHR P16473 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ TP53 P04637 1/20 0.69
▸ CYP3A4 P08684 1/20 0.69
▸ ALOX15 P16050 1/20 0.69
▸ ALOX12 P18054 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ HIF1A Q16665 1/20 0.69
▸ HSD17B10 Q99714 1/20 0.69
▸ DNM1 Q05193 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL6697913 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL29840251 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL8036783 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL22384 0.96 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL71525 0.96 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL2007037 0.96 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL25266692 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL5069703 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL1250868 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL4260120 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260086684-A1 DISPLAY DEVICE AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2026-03-26 — — US disclosed
EP-3098855-B1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO LTD (KR) 2022-10-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260086684-A1 DISPLAY DEVICE AND ELECTRONIC DEVICE INCLUDING THE SAME L1CAM, CD274, ICOSLG SLC22A1 3754/4885SLC22A2 3587/4885TSHR 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback